Back to newsIdeaya Biosciences target price cut to $39 from $44 by MizuhoIIDYA•2026-11-10Mizuho cut its target price for Ideaya Biosciences to $39 from $44.Related NewsCCalciMedica Q3 net loss narrows 78% to $1.7 millionCALC•2026-11-10MMetLife target price raised to $107 from $87MET•2026-11-10MManchester United sets fiscal 2027 first-quarter results releaseMANU•2026-11-10CCullinan Therapeutics Q3 net loss narrows to $49.4 millionCGEM•2026-11-10LLegend Biotech names Ingrid Zhang CEOLEGN•2026-11-10
IDYA•IDYA•IDYA•IDYA•
